Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF18 antibody

This Rat Monoclonal antibody specifically detects TNFRSF18 in FACS and BR. It exhibits reactivity toward Mouse. It has been mentioned in 5+ publications
Catalog No. ABIN1176970
Shipping to: United States
Contact our Customer Service for availability and price in your country. Contact Info

Quick Overview for TNFRSF18 antibody (ABIN1176970)

Target

See all TNFRSF18 Antibodies
TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))

Reactivity

  • 99
  • 91
  • 24
Mouse

Host

  • 72
  • 41
  • 39
  • 22
Rat

Clonality

  • 103
  • 69
  • 2
Monoclonal

Conjugate

  • 87
  • 12
  • 11
  • 8
  • 8
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TNFRSF18 antibody is un-conjugated

Application

  • 83
  • 42
  • 38
  • 21
  • 14
  • 13
  • 13
  • 12
  • 6
  • 6
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Flow Cytometry (FACS), Blocking Reagent (BR)

Clone

DTA
  • Purification

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Sterility

    0.2 μm filtered

    Endotoxin Level

    Endotoxin level is ≤ 0.01 EU/μg (≤ 0.001 ng/μg) of protein as determined by the LAL assay.

    Immunogen

    Mouse CD25+ CD4+ T Cell Line

    Isotype

    IgG2b
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.0 mg/mL

    Buffer

    No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered.

    Preservative

    Azide free

    Storage

    4 °C

    Storage Comment

    Store undiluted at 4°C. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
  • Ko, Yamazaki, Nakamura, Nishioka, Hirota, Yamaguchi, Shimizu, Nomura, Chiba, Sakaguchi: "Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells." in: The Journal of experimental medicine, Vol. 202, Issue 7, pp. 885-91, (2005) (PubMed).

    Ji, Liao, Faubion, Abadía-Molina, Cozzo, Laroux, Caton, Terhorst: "Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 10, pp. 5823-7, (2004) (PubMed).

    Tone, Tone, Adams, Yates, Frewin, Cobbold, Waldmann: "Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Issue 25, pp. 15059-64, (2003) (PubMed).

    Shimizu, Yamazaki, Takahashi, Ishida, Sakaguchi: "Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance." in: Nature immunology, Vol. 3, Issue 2, pp. 135-42, (2002) (PubMed).

    Nocentini, Giunchi, Ronchetti, Krausz, Bartoli, Moraca, Migliorati, Riccardi: "A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 12, pp. 6216-21, (1997) (PubMed).

  • Target

    TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))

    Alternative Name

    GITR

    Background

    The DTA-1 antibody reacts with GITR [Glucocorticoid-induced Tumor necrosis factor (TNF) receptor family-Related], a 66-70-kDa homodimer glycoprotein that is a member of the TNF receptor superfamily and is also known as TNFRSF18. As its name implies, GITR expression was first detected in T lymphocytes that had been treated with dexamethasone, a glucocorticoid. In normal naive mice, GITR is expressed at moderate levels on CD25-positive/CD4-positive/CD8a-negative thymocytes and on CD25-positive/CD4-positive/CD45RB-low splenocytes. It is also expressed at low levels on splenic CD25-negative/CD4-positive/CD45RB-low T lymphocytes, B lymphocytes, macrophages, and dendritic cells. Activation of T and B lymphocytes upregulates GITR expression. GITR is a costimulatory receptor that plays an important role in Regulatory T (Treg)-cell functions, and a GITR Ligand has been detected on B lymphocytes, macrophages, and dendritic cells. mAb DTA-1 abrogates suppression by Treg cells without affecting their proliferative response, while it is co-stimulatory for T lymphocytes that are not Treg cells.

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!